University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States
NCT Number: NCT06354049
The purpose of this research is to investigate the delivery of Reiki to integrative oncology patients and assess its potential for improving cancer-related symptoms in this population.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Interventional
Not applicable
Cleveland, Ohio, 44106, United States
Reiki is a biofield therapy originating in Japan, in which a trained practitioner places their hands on or above the body of a receiver or themselves to generate a relaxation and healing response. Systematic reviews and meta-analyses report Reiki to be effective for improving psychological and physical health symptoms. With respect to adults with cancer, Reiki has been shown to improve participants' relaxation, pain, fatigue, sleep, anxiety, stress, and wellbeing/quality of life compared to care as usual. However, one study showed no improvement in comfort and wellbeing in those receiving Reiki compared to sham Reiki control, but those receiving Reiki reported improvements above usual care.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Reiki, originating in Japan, is a biofield therapy where a skilled practitioner places their hands on or above the body of the recipient or themselves to induce relaxation and promote healing.
Time frame: 8 weeks post enrollment
Calculated by total number of participants enrolled/ total number of participants eligible and 90% is considered successful for the recruitment rate.
Time frame: 8 weeks post enrollment
Calculated by number of participants retained until the final survey time point / number of participants enrolled. 70% of participant retention until the final survey time point will be considered successful.
Time frame: 8 weeks post enrollment
Total number of sessions attended per 6 sessions. Attendance rate of >/= 70% will be considered successful
Time frame: 8 weeks post enrollment
Number of participants treated in manner consistent with intervention/total number of participants enrolled
Time frame: 8 weeks post enrollment
As assessed by participants mean for the Participants' satisfaction survey with the Reiki sessions, measured on a scale from 0 (Not at all satisfied) to 10 (Completely satisfied)
Time frame: 8 weeks post enrollment
Data completeness of >/= 90% is considered satisfactory
Time frame: Baseline, 8 weeks
Changes from baseline in Physical Function, Anxiety, Depression, Fatigue, Sleep Disturbance, Ability to Participate in Social Activities, Pain Interference all measured by T-score, a 11 point numerical rating scale, with higher scores representing more pain calculated from a 5 point Likert scale, with higher scores representing more of the concept being measured.
Time frame: Upto 8 weeks
The rate of intensity of common cancer symptoms, including pain, nausea, anxiety, fatigue, and well-being as measured using ESAS scale of 0 to 10 where, 0 is no pain to 10 as worst possible pain.
Case Comprehensive Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05506878
Abdominal Pain, Agnosia
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05628246
Agnosia, Cancer Pain
Bangkoknoi, Bangkok, Thailand
View Trial DetailsNCT06035731
Anxiety Depression, Breast Diseases
Nice, France
View Trial DetailsNCT06432998
Cancer Pain, Head and Neck Neoplasms
Santa Cruz de Tenerife, Tenerife, Spain
View Trial Details